Posters & Publications
Preclinical efficacy of BIO101 on respiratory function in SARS-CoV-2-infected Syrian hamsters. Latil et al. Poster presented at 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). 9-12th July 2021.
Ecysteroid metabolism in mammals: the fate of ingested 20-hydroxyecdysone in mice and rats. Dinan et al. Article published in Journal of Steroid Biochemistry and Molecular Biology, 212: 105896. https://doi.org/10.1016/j.jsbmb.2021.105896.
The complex metabolism of poststerone in male rats. Balducci et al. Published in Journal of Steroid Biochemistry and Molecular Biology. 212: 105897. https://doi.org/10.1016/j.jsbmb.2021.105897.
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomized controlled trial. Dioh et al. Article published in Trials, 22:42.
20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases. Dinan et al. Article published in Biomedicines, 9 (5): 492. doi: 10.3390/biomedicines9050492.
Developing new drugs activating the protective arm of the Renin Angiotensin System as a potential treatment of respiratory failure in COVID-19 patients. Latil et al. Article published in Drug Discovery Today, 26 (5), 1311-1318.